Translational Research In Oncology Us Inc is located in Los Angeles, CA. The organization was established in 2005. According to its NTEE Classification (H30) the organization is classified as: Cancer Research, under the broad grouping of Medical Research and related organizations. This organization is an independent organization and not affiliated with a larger national or regional group of organizations. Translational Research In Oncology Us Inc is a 501(c)(3) and as such, is described as a "Charitable or Religous organization or a private foundation" by the IRS.
For the year ending 12/2022, Translational Research In Oncology Us Inc generated $9.6m in total revenue. This represents relatively stable growth, over the past 8 years the organization has increased revenue by an average of 3.5% each year. All expenses for the organization totaled $6.8m during the year ending 12/2022. While expenses have increased by 1.1% per year over the past 8 years. They've been increasing with an increasing level of total revenue. You can explore the organizations financials more deeply in the financial statements section below.
| Name (title) | Role | Hours | Compensation |
|---|---|---|---|
Dennis Slamon President/se | 0.5 | $0 | |
John Glaspy Vice President | 0.5 | $0 | |
James Muff CFO | 16 | $77,860 | |
Meghan Brennan COO | 40 | $385,414 | |
Karen Ibara Finance Admin | 40 | $85,922 | |
Shannon Ibara Finance Director | 40 | $175,414 |
| Vendor Name (Service) | Service Year | Compensation |
|---|---|---|
Cancer Center Of Kansas Pa | 12/30/22 | $262,356 |
The Regents Of The University Of California | 12/30/22 | $1,428,709 |
Fort Wayne Medical Oncology & Hematology | 12/30/22 | $367,864 |
Orlando Health Inc | 12/30/22 | $217,496 |
Ucla Jonsson Cancer Center Foundation | 12/30/22 | $1,600,000 |
| Statement of Revenue | |
|---|---|
| Contributions, Gifts, Grants & Similar | $9,729,510 |
| Interest on Savings | $1,772 |
| Dividends & Interest | $142,336 |
| Net Rental Income | $0 |
| Net Gain on Sale of Assets | -$301,523 |
| Capital Gain Net Income | $0 |
| Net ST Capital Gain | $0 |
| Income Modifications | $0 |
| Profit on Inventory Sales | $0 |
| Other Income | $0 |
| Total Revenue | $9,572,095 |
| Statement of Expenses | |
|---|---|
| Compensation of officers, directors, trustees, etc | $463,274 |
| Other employee salaries and wages | $1,521,561 |
| Pension plans, employee benefits | $0 |
| Interest | $0 |
| Taxes | $5,900 |
| Depreciation | $0 |
| Occupancy | $85,144 |
| Travel, conferences, and meetings | $266,269 |
| Printing and publications | $0 |
| Other expenses | $4,344,943 |
| Total operating and administrative expenses | $6,840,339 |
| Contributions, gifts, grants paid | $0 |
| Total expenses and disbursements | $6,840,339 |
| Balance Sheet | |
|---|---|
| Cash—non-interest-bearing | $7,350,335 |
| Savings and temporary cash investments | $0 |
| Net Accounts receivable | $4,878,462 |
| Net Pledges Receivable | $0 |
| Grants receivable | $0 |
| Receivables from Officers, Directors, or Controlling Persons | $0 |
| Net other notes and loans receivable | $0 |
| Inventories for sale or use | $0 |
| Prepaid expenses and deferred charges | $68,449 |
| Net Investments - land, buildings, equipment | $0 |
| Investments—mortgage loans | $0 |
| Investments—other | $10,517,470 |
| Net Land, buildings, and equipment | $0 |
| Other assets | $0 |
| Total assets | $22,814,716 |
| Accounts payable and accrued expenses | $5,822,854 |
| Grants payable | $0 |
| Deferred revenue | $3,186,471 |
| Loans and other payables to any current Officer, Director, or Controlling Person | $0 |
| Mortgages and other notes payable | $0 |
| Other liabilities | $0 |
| Total liabilities | $9,009,325 |